Potential of GLP-1 Agonists in Alzheimer's Disease
Thanks for listening to The Peptide Podcast.
Alzheimer's disease is a type of dementia characterized by memory loss, cognitive decline, and a decline in the ability to perform daily tasks (e.g., planning and organizing). It can also affect mood and personality and impair judgment and language. Research has shown that Alzheimer's results from amyloid plaques and neurofibrillary tangles in brain tissue, which affect communication between brain neurons.
Read the Full Episode Transcript:
https://pepties.com/potential-of-glp-1-agonists-in-alzheimers-disease/
Dr. Nikki's Qualifications…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.